Roche Diabetes Care v Tandem Diabetes Care (CFI, 9 September 2024)
| Date | 9 September 2024 |
|---|---|
| Court | CFI |
| Division | Hamburg (DE) Local Division |
| Type of action | Generic application |
| Registry reference | App_28467/2024 · ORD_28786/2024 |
| Parties | Tandem Diabetes Care, Inc., Tandem Diabetes Care Europe B.V., |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 9 September 2024 (UPC_CFI_88/2024, ACT_10800/2024, ORD_28786/2024), the Hamburg Local Division (S. Klepsch, presiding and judge-rapporteur, S. Schilling, T. Zhilova, G. Checcacci) dismissed the request by Tandem Diabetes Care, Inc. and Tandem Diabetes Care Europe B.V. to stay Roche Diabetes Care’s infringement action on EP 2 196 231 pending the revocation action they had brought on 30 November 2023 before the Paris Central Division. It also refused to hear infringement and validity together in Hamburg, and granted leave to appeal.
Question
Should a local division stay infringement proceedings where an earlier revocation action is pending before the Central Division?
Decision
The division exercises the discretion conferred by Art. 33(3) and (5) UPCA and Rule 75 RoP to proceed. Following the Court of Appeal’s order of 28 May 2024, a stay must in principle be ruled out, having regard to the right to an effective remedy within a reasonable time and the aim of a final oral hearing within one year. The risk of irreconcilable decisions does not require a stay, as the panel deciding last can take the Central Division’s decision into account. The claimant’s interest prevails, the outcome of the revocation action being uncertain in timing and substance, and the parties to the two sets of proceedings are not identical. The division need not assess the likelihood of invalidity and, for the time being, does not follow the judge-rapporteur’s provisional view of 14 June 2024 that it could hear the defendants’ revocation action.
Key points for practice
- Practical point: filing a revocation action first before the Central Division is not enough to obtain a stay of the infringement action, even where the patentee files numerous auxiliary requests.
Provisions applied
- Agreement on a Unified Patent Court
- Arts. 33(3) and (5) and 73(2)(b)(ii)
- Rules of Procedure
- Rules 37, 75, 220.2 and 295
- Case law cited
- Carrier v BITZER Electronics, Court of Appeal, 28 May 2024 (UPC_CoA_22/2024)
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Court fees and costs (UPC).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantTandem Diabetes Care Europe B.V.10 decisions in the corpusFollow this party
- claimantTandem Diabetes Care, Inc.9 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Generic application
- Outcome (Dhenne Avocats summary)
- La division locale de Hambourg refuse de surseoir à statuer sur l'action en contrefaçon dans l'attente de l'action en nullité pendante devant la division centrale, refuse d'instruire ensemble les deux actions et autorise l'appel.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 2 196 231mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Carrier v BITZER Electronics (CoA, 28 May 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 2 196 231System for ambulatory drug infusion comprising a filling apparatus for flexible containers recorded proprietor: F Hoffmann La Roche AG et Roche Diagnostics GmbH | Mentioned in the analysis (role not qualified) Also mentioned in 9 other decision(s): Tandem Diabetes Care Europe v Roche Diabetes Care (CFI, 18 December 20 · Tandem Diabetes Care Europe v Roche Diabetes Care (CoA, 3 July 2025) · Tandem Diabetes Care Europe v Roche Diabetes Care (CoA, 5 June 2025) · Roche Diabetes Care v Tandem Diabetes Care (CFI, 26 July 2024) · Tandem Diabetes Care v Roche Diabetes Care (CFI, 27 June 2024) · Tandem Diabetes Care v Roche Diabetes Care (CFI, 10 May 2024) · Tandem Diabetes Care v Roche Diabetes Care (CFI, ORD_9062/2024, 20 Feb · Tandem Diabetes Care v Roche Diabetes Care (CFI, ORD_9060/2024, 20 Feb | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.